146 related articles for article (PubMed ID: 11043158)
1. In vivo proton magnetic resonance spectroscopy in phenylketonuria.
Möller HE; Ullrich K; Weglage J
Eur J Pediatr; 2000 Oct; 159 Suppl 2():S121-5. PubMed ID: 11043158
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of phenylalanine transport at the human blood-brain barrier investigated in vivo.
Möller HE; Weglage J; Wiedermann D; Vermathen P; Bick U; Ullrich K
Brain Res; 1997 Dec; 778(2):329-37. PubMed ID: 9459550
[TBL] [Abstract][Full Text] [Related]
3. Blood-brain barrier phenylalanine transport and individual vulnerability in phenylketonuria.
Möller HE; Weglage J; Wiedermann D; Ullrich K
J Cereb Blood Flow Metab; 1998 Nov; 18(11):1184-91. PubMed ID: 9809507
[TBL] [Abstract][Full Text] [Related]
4. Brain imaging and proton magnetic resonance spectroscopy in patients with phenylketonuria.
Möller HE; Weglage J; Bick U; Wiedermann D; Feldmann R; Ullrich K
Pediatrics; 2003 Dec; 112(6 Pt 2):1580-3. PubMed ID: 14654669
[TBL] [Abstract][Full Text] [Related]
5. Blood-brain phenylalanine relationships in persons with phenylketonuria.
Koch R; Moats R; Guttler F; Guldberg P; Nelson M
Pediatrics; 2000 Nov; 106(5):1093-6. PubMed ID: 11061780
[TBL] [Abstract][Full Text] [Related]
6. Future role of large neutral amino acids in transport of phenylalanine into the brain.
Matalon R; Surendran S; Matalon KM; Tyring S; Quast M; Jinga W; Ezell E; Szucs S
Pediatrics; 2003 Dec; 112(6 Pt 2):1570-4. PubMed ID: 14654667
[TBL] [Abstract][Full Text] [Related]
7. Individual blood-brain barrier phenylalanine transport in siblings with classical phenylketonuria.
Weglage J; Wiedermann D; Denecke J; Feldmann R; Koch HG; Ullrich K; Möller HE
J Inherit Metab Dis; 2002 Oct; 25(6):431-6. PubMed ID: 12555936
[TBL] [Abstract][Full Text] [Related]
8. Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria.
Pietz J; Kreis R; Rupp A; Mayatepek E; Rating D; Boesch C; Bremer HJ
J Clin Invest; 1999 Apr; 103(8):1169-78. PubMed ID: 10207169
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuria.
Leuzzi V; Bianchi MC; Tosetti M; Carducci CL; Carducci CA; Antonozzi I
J Inherit Metab Dis; 2000 Sep; 23(6):563-70. PubMed ID: 11032331
[TBL] [Abstract][Full Text] [Related]
10. Identification and quantitation of phenylalanine in the brain of patients with phenylketonuria by means of localized in vivo 1H magnetic-resonance spectroscopy.
Kreis R; Pietz J; Penzien J; Herschkowitz N; Boesch C
J Magn Reson B; 1995 Jun; 107(3):242-51. PubMed ID: 7788097
[TBL] [Abstract][Full Text] [Related]
11. Blood-brain barrier transport of amino acids in healthy controls and in patients with phenylketonuria.
Knudsen GM; Hasselbalch S; Toft PB; Christensen E; Paulson OB; Lou H
J Inherit Metab Dis; 1995; 18(6):653-64. PubMed ID: 8750601
[TBL] [Abstract][Full Text] [Related]
12. Individual blood-brain barrier phenylalanine transport determines clinical outcome in phenylketonuria.
Weglage J; Wiedermann D; Denecke J; Feldmann R; Koch HG; Ullrich K; Harms E; Möller HE
Ann Neurol; 2001 Oct; 50(4):463-7. PubMed ID: 11601498
[TBL] [Abstract][Full Text] [Related]
13. Comments on in vivo proton magnetic resonance spectroscopy in phenylketonuria.
Kreis R
Eur J Pediatr; 2000 Oct; 159 Suppl 2():S126-8. PubMed ID: 11221741
[No Abstract] [Full Text] [Related]
14. In vivo measurement of phenylalanine in human brain by proton nuclear magnetic resonance spectroscopy.
Novotny EJ; Avison MJ; Herschkowitz N; Petroff OA; Prichard JW; Seashore MR; Rothman DL
Pediatr Res; 1995 Feb; 37(2):244-9. PubMed ID: 7731764
[TBL] [Abstract][Full Text] [Related]
15. The dynamics of brain concentrations of phenylalanine and its clinical significance in patients with phenylketonuria determined by in vivo 1H magnetic resonance spectroscopy.
Pietz J; Kreis R; Boesch C; Penzien J; Rating D; Herschkowitz N
Pediatr Res; 1995 Nov; 38(5):657-63. PubMed ID: 8552430
[TBL] [Abstract][Full Text] [Related]
16. Inter-individual variation in brain phenylalanine concentration in patients with PKU is not caused by genetic variation in the 4F2hc/LAT1 complex.
Møller LB; Paulsen M; Koch R; Moats R; Guldberg P; Güttler F
Mol Genet Metab; 2005 Dec; 86 Suppl 1():S119-23. PubMed ID: 16176881
[TBL] [Abstract][Full Text] [Related]
17. [Quantification of phenylalanine in the brain of patients with hyperphenylalaninemia by (1)H magnetic resonance spectroscopy].
Wang KD; Zhou ZS; Shen M; Hong W; Yu WM
Zhonghua Er Ke Za Zhi; 2009 Feb; 47(2):119-23. PubMed ID: 19573458
[TBL] [Abstract][Full Text] [Related]
18. Variability of blood-brain ratios of phenylalanine in typical patients with phenylketonuria.
Rupp A; Kreis R; Zschocke J; Slotboom J; Boesch C; Rating D; Pietz J
J Cereb Blood Flow Metab; 2001 Mar; 21(3):276-84. PubMed ID: 11295882
[TBL] [Abstract][Full Text] [Related]
19. Phenylalanine can be detected in brain tissue of healthy subjects by 1H magnetic resonance spectroscopy.
Pietz J; Lutz T; Zwygart K; Hoffmann GF; Ebinger F; Boesch C; Kreis R
J Inherit Metab Dis; 2003; 26(7):683-92. PubMed ID: 14707517
[TBL] [Abstract][Full Text] [Related]
20. Cerebral energy metabolism in phenylketonuria: findings by quantitative In vivo 31P MR spectroscopy.
Pietz J; Rupp A; Ebinger F; Rating D; Mayatepek E; Boesch C; Kreis R
Pediatr Res; 2003 Apr; 53(4):654-62. PubMed ID: 12612190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
